Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TFEC |
| Upstream (Parents) |
|---|
| (<<) CD53 → TFEC |
| (<<) TYROBP → TFEC |
| (<<) CD86 → TFEC |
| Downstream (Children) |
|---|
| TFEC → TAAR3 (>>) |
| TFEC → CD1B (>>) |
| TFEC → CD84 (>>) |
| TFEC → CCL22 (>>) |
| TFEC → LILRA4 (>>) |
| TFEC → ACP5 (>>) |
| TFEC → IL2RA (>>) |
| TFEC → PLA2G7 (>>) |
| TFEC → BTG3 (>>) |
| TFEC → SLC7A7 (>>) |
| TFEC → TYROBP (>>) |
| TFEC → CD86 (>>) |
| TFEC → CCL3L3///CCL3L1///CCL3 (>>) |
